www.biorxiv.org/content/10.6...
#Neuroscience
www.biorxiv.org/content/10.6...
#Neuroscience
📢 This review explores the underlying disease mechanisms and emerging strategies for targeted therapies.
🔗 Read more: www.nature.com/articles/s41...
📢 This review explores the underlying disease mechanisms and emerging strategies for targeted therapies.
🔗 Read more: www.nature.com/articles/s41...
#Neuroscience
#Neuroscience
#Neuroscience
#Neuroscience
#Neuroscience
#Neuroscience
Biochemistry alumna Abhipsa Shatarupa is first/co-first author on three recent publications advancing research in DNA replication and KIF1A-associated neurological disease.
#StructuralBiology #CryoEM
Links to all three publications are in the comments:
Biochemistry alumna Abhipsa Shatarupa is first/co-first author on three recent publications advancing research in DNA replication and KIF1A-associated neurological disease.
#StructuralBiology #CryoEM
Links to all three publications are in the comments:
rupress.org/jcb/article/...
#Cytoskeleton #Disease #Neuroscience #Trafficking
rupress.org/jcb/article/...
#Cytoskeleton #Disease #Neuroscience #Trafficking
Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development
Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development
CONCLUSIONS: CM activates an SP1-TET1 epigenetic regulatory module that demethylates and activates the Kif1a promoter, thereby linking (🧵 8/9)
CONCLUSIONS: CM activates an SP1-TET1 epigenetic regulatory module that demethylates and activates the Kif1a promoter, thereby linking (🧵 8/9)